Wei Liu

机构：University of Chicago · ORCID：0000-0003-0696-6407

发表论文 86 篇 · 总被引 1936 次 · h-index 26

代表论文

• Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial (2025 · The Lancet Oncology · 被引 62)
• In situ expansion and reprogramming of Kupffer cells elicit potent tumoricidal immunity against liver metastasis (2023 · Journal of Clinical Investigation · 被引 51)
• Atrazine promotes breast cancer development by suppressing immune function and upregulating MMP expression (2023 · Ecotoxicology and Environmental Safety · 被引 27)
• USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma (2023 · Cell Death and Disease · 被引 24)
• E3 Ubiquitin Ligase RNF13 Suppresses TLR Lysosomal Degradation by Promoting LAMP‐1 Proteasomal Degradation (2024 · Advanced Science · 被引 18)
• A novel recombination protein C12ORF40/REDIC1 is required for meiotic crossover formation (2023 · Cell Discovery · 被引 15)